CROSSJECT (XPAR:ALCJ) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAR:ALCJ CROSSJECT XPAR:ALCJ
25 GF Score
Price €1.50
! 4 Warning Signs
View Full Analysis

What is CROSSJECT Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

XPAR:ALCJ
25GF Score
CROSSJECT XPAR:ALCJ
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CROSSJECT Business Description

Other Exchanges 74C:Germany
Address 60L avenue du 14 Juillet, Chenôve, FRA, 21300
CROSSJECT manufactures and markets needle-free drug self-injection system.
25GF Score

Get the complete analysis for XPAR:ALCJ

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.50
Price